Clinical data | |
---|---|
Other names | 2-Methyl-5α-androst-1-en-17β-ol-3-one; 2-Methyl-δ1-4,5α-dihydrotestosterone; 2-Methyl-δ1-DHT; Deacetylanatrofin |
Routes of administration | Intramuscular injection (as stenbolone acetate) |
Drug class | Androgen; Anabolic steroid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C20H30O2 |
Molar mass | 302.458 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Stenbolone is an anabolic–androgenic steroid (AAS) of the dihydrotestosterone (DHT) group which was never marketed. [1] [2] [3] [4] A C17β ester prodrug of stenbolone, stenbolone acetate, is used as an AAS for depot intramuscular injection under the brand names Anatrofin and Stenobolone. [1] [3]
Stenbolone, also known as 2-methyl-δ1-4,5α-dihydrotestosterone (2-methyl-δ1-DHT) or as 2-methyl-5α-androst-1-en-17β-ol-3-one, is a synthetic androstane steroid and a derivative of DHT. [1] [3] It is closely related structurally to drostanolone (2-methyl-DHT), 1-testosterone (δ1-DHT), and methylstenbolone (17α-methylstenbolone). [5]
Stenbolone is the generic name of the drug and its INN . [1] [3] [4]